ILLUMINA NEXTSEQ REAGENT KITS Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Thu Dec 22 18:00:00 GMT 2022
ILLUMINA INC:1107104 [21-002130] - THE GENOME ANALYZER CORE FACILITY WITHIN NIAMS REQUESTS THE PURCHASE OF SEQUENCING REAGENT KITS FOR OUR ILLUMINA NOVASEQ 6000 AND NEXTSEQ 550. THESE KITS ARE EXTREME... Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025
Illumina CAT #20050264 or equal; NEXTSEQ 1000/2000 P1 REAGENTS (300 cycles); Illumina CAT #20075294 or equal; NEXTSEQ 1000/2000 P1 REAGENTS (600 CYCLES) for the DSHS Lab.
A solicitation document will NOT be issued, and quotations will NOT be requested.The National Institutes of Health (NIH) intends to award a firm fixed price to Illumina Incorporated of San Diego, California 92122.The purpose of this acquisition is to purchase one NextSeq 500/550 High Output Kit v2.5 (300 Cycles) Reagent kit from Illumina Incorporated.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc. for NextSeq reagents. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2134670 and the solicitation is issued as a Request for Quotes (RFQ).This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and i...
The Centers for Disease Control and Prevention intends to award a sole source firm-fixed price purchase order contract to Illumina, Inc. for reagents compatible with Illumina MiSeq and NextSeq instruments. Illumina is the sole manufacturer, distributor, and service provider of these instruments and compatible reagents and are proprietary to the Manufacturer.
